• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

选择性腺苷受体激动剂对麻醉大鼠的肾脏影响。

Renal effects of selective adenosine receptor agonists in anesthetized rats.

作者信息

Churchill P C, Bidani A

出版信息

Am J Physiol. 1987 Feb;252(2 Pt 2):F299-303. doi: 10.1152/ajprenal.1987.252.2.F299.

DOI:10.1152/ajprenal.1987.252.2.F299
PMID:3028172
Abstract

Exogenous adenosine affects renal hemodynamics, renal tubular transport processes, and the secretion of renin. However, adenosine is not a selective agonist; it activates both A1 and A2 cell-surface receptors and it binds to an intracellular P-site that inhibits adenylate cyclase activity. Recent in vitro studies have suggested that activation of A1- and A2- adenosine receptors results in opposite effects on renin secretion. The purpose of these experiments was to examine the renal effects of A1- and A2-adenosine receptor agonists in vivo. 5'-N-ethylcarboxamide adenosine (NECA), 2-chloroadenosine (2-CLA), and N6-cyclohexyladenosine (CHA) were infused intravenously at rates that produced comparable decreases in systemic arterial blood pressure. All three of these adenosine analogues produced comparable decreases in para-aminohippurate (PAH) and inulin clearances and in Na and K excretion rates. CHA, an A1-selective agonist, markedly decreased plasma renin concentration (PRC), whereas NECA, an A2-selective agonist, markedly increased PRC; 2-CLA, a nonselective agonist, produced a smaller increase in PRC. Taken together, these results suggest that occupation of A1- and A2-receptors inhibits and stimulates renin secretion in vivo, independently of the effects of these adenosine receptor agonists on arterial blood pressure, renal hemodynamics, and tubular Na and K transport.

摘要

外源性腺苷会影响肾血流动力学、肾小管转运过程以及肾素分泌。然而,腺苷并非选择性激动剂;它既能激活A1和A2细胞表面受体,又能与抑制腺苷酸环化酶活性的细胞内P位点结合。最近的体外研究表明,A1和A2腺苷受体的激活对肾素分泌产生相反的影响。这些实验的目的是在体内研究A1和A2腺苷受体激动剂对肾脏的作用。以能使体循环动脉血压产生类似下降的速率静脉输注5'-N-乙基甲酰胺腺苷(NECA)、2-氯腺苷(2-CLA)和N6-环己基腺苷(CHA)。这三种腺苷类似物均使对氨基马尿酸(PAH)清除率、菊粉清除率以及钠和钾排泄率出现类似程度的下降。CHA是一种A1选择性激动剂,可显著降低血浆肾素浓度(PRC),而NECA是一种A2选择性激动剂,可显著升高PRC;2-CLA是一种非选择性激动剂,使PRC有较小幅度的升高。综上所述,这些结果表明,在体内占据A1和A2受体分别抑制和刺激肾素分泌,这与这些腺苷受体激动剂对动脉血压、肾血流动力学以及肾小管钠和钾转运的影响无关。

相似文献

1
Renal effects of selective adenosine receptor agonists in anesthetized rats.选择性腺苷受体激动剂对麻醉大鼠的肾脏影响。
Am J Physiol. 1987 Feb;252(2 Pt 2):F299-303. doi: 10.1152/ajprenal.1987.252.2.F299.
2
Effects of adenosine receptor agonists in the isolated, perfused rat kidney.腺苷受体激动剂对离体灌注大鼠肾脏的影响。
Am J Physiol. 1984 Sep;247(3 Pt 2):H343-8. doi: 10.1152/ajpheart.1984.247.3.H343.
3
A1 and A2 adenosine receptor activation inhibits and stimulates renin secretion of rat renal cortical slices.A1和A2腺苷受体激活分别抑制和刺激大鼠肾皮质切片的肾素分泌。
J Pharmacol Exp Ther. 1985 Mar;232(3):589-94.
4
Concentration dependency of the renal vascular and renin secretory responses to adenosine receptor agonists.
J Pharmacol Exp Ther. 1985 Jan;232(1):189-93.
5
Effects of adenosine-receptor agonists on renin release in anaesthetized rats.腺苷受体激动剂对麻醉大鼠肾素释放的影响。
J Hypertens. 1995 Dec;13(12 Pt 2):1753-7.
6
Effects of renal denervation on the renal responses of anesthetized rats to cyclohexyladenosine.
Can J Physiol Pharmacol. 1984 Aug;62(8):934-8. doi: 10.1139/y84-156.
7
Renal actions of a new adenosine agonist, CGS 21680A selective for the A2 receptor.一种对A2受体具有选择性的新型腺苷激动剂CGS 21680A的肾脏作用。
J Pharmacol Exp Ther. 1991 Jun;257(3):1005-12.
8
Effects of adenosine receptor agonists on renal function in anaesthetized rats.腺苷受体激动剂对麻醉大鼠肾功能的影响。
J Hypertens. 1997 Dec;15(12 Pt 2):1785-9. doi: 10.1097/00004872-199715120-00090.
9
Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.用[3H]NECA标记的大鼠纹状体膜中A2腺苷受体的特性研究。
Mol Pharmacol. 1986 Apr;29(4):331-46.
10
Cardiovascular effects of adenosine A2 agonists in the conscious spontaneously hypertensive rat: a comparative study of three structurally distinct ligands.腺苷A2激动剂对清醒自发性高血压大鼠的心血管作用:三种结构不同配体的比较研究
J Pharmacol Exp Ther. 1991 Dec;259(3):1203-12.

引用本文的文献

1
Adenosine receptors as emerging therapeutic targets for diabetic kidney disease.腺苷受体作为糖尿病肾病新出现的治疗靶点
Kidney Res Clin Pract. 2022 Sep;41(Suppl 2):S74-S88. doi: 10.23876/j.krcp.22.011. Epub 2022 Aug 22.
2
Regionally selective cardiovascular responses to adenosine A and A receptor activation.腺苷 A 受体激活的区域性选择性心血管反应。
FASEB J. 2022 Apr;36(4):e22214. doi: 10.1096/fj.202101945R.
3
The role of calcium in the regulation of renin secretion.钙在肾素分泌调节中的作用。
Am J Physiol Renal Physiol. 2010 Jan;298(1):F1-F11. doi: 10.1152/ajprenal.00143.2009. Epub 2009 Jul 29.
4
Adenosine receptors and the kidney.腺苷受体与肾脏。
Handb Exp Pharmacol. 2009(193):443-70. doi: 10.1007/978-3-540-89615-9_15.
5
Adenosine and kidney function: potential implications in patients with heart failure.腺苷与肾功能:对心力衰竭患者的潜在影响
Eur J Heart Fail. 2008 Feb;10(2):176-87. doi: 10.1016/j.ejheart.2008.01.010. Epub 2008 Feb 1.
6
Adenosine A1 receptors in contrast media-induced renal dysfunction in the normal rat.腺苷A1受体在正常大鼠造影剂诱导的肾功能障碍中的作用
Eur Radiol. 2004 Jul;14(7):1297-302. doi: 10.1007/s00330-003-2167-2. Epub 2004 Jan 9.
7
Acute effect of low dose theophylline on the circulatory disturbances of cirrhosis.低剂量茶碱对肝硬化循环障碍的急性影响
Gut. 1997 Jan;40(1):139-44. doi: 10.1136/gut.40.1.139.
8
Adenosine receptor prodrugs: towards kidney-selective dialkylxanthines.腺苷受体前药:迈向肾脏选择性二烷基黄嘌呤
J Pharmacol Exp Ther. 1989 Jul;250(1):79-85.
9
Adenosine inhibits renin release induced by suprarenal-aortic constriction and prostacyclin.腺苷可抑制由肾上主动脉缩窄和前列环素诱导的肾素释放。
Naunyn Schmiedebergs Arch Pharmacol. 1989 May;339(5):590-5. doi: 10.1007/BF00167266.
10
Adenosine stimulates Ca2+ fluxes and increases cytosolic free Ca2+ in cultured rat mesangial cells.腺苷可刺激培养的大鼠系膜细胞中的钙离子通量,并增加细胞溶质中的游离钙离子。
Biochem J. 1992 Mar 15;282 ( Pt 3)(Pt 3):871-6. doi: 10.1042/bj2820871.